Abbott Laboratories stock underperforms Thursday when compared to competitors
The stock's fall snapped a four-day winning streak.
Fintel on MSN4d
Oppenheimer Initiates Coverage of Abbott Laboratories (ABT) with Outperform Recommendation
Fintel reports that on October 8, 2024, Oppenheimer initiated coverage of Abbott Laboratories (NYSE:ABT) with a Outperform ...
Buy Rating on Abbott Laboratories: Swift Clinical Advances and Strategic International Expansion
Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
Abbott Laboratories' (NYSE:ABT) five-year earnings growth trails the respectable shareholder returns
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, ...
ETF Daily News2d
Somerset Trust Co Reduces Stock Holdings in Abbott Laboratories (NYSE:ABT)
Somerset Trust Co lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.6% in the 3rd quarter, ...
Hosted on MSN10d
Abbott's Quarterly Earnings Preview: What You Need to Know
Based in Abbott Park, Illinois, Abbott Laboratories (ABT) is a global healthcare company that develops a broad range of ...
Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 77% of the company
Every investor in Abbott Laboratories ( NYSE:ABT) should be aware of the most powerful shareholder groups. The group holding ...
Mattson Financial Services LLC Cuts Position in Abbott Laboratories (NYSE:ABT)
Mattson Financial Services LLC cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 0.7% in the 3rd quarter, ...
Buy Rating Affirmed for Abbott Laboratories Amid Strong Performance and Favorable Market Trends
Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
Abbott Laboratories started at Outperform by Oppenheimer on favorable risk/reward
Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE: ABT) with an Outperform rating and a price ...
BioWorld3d
Abbott advancing PFA studies, launches cardiac mapping tool
Abbott Laboratories reported it achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment in ...